Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

0.2922
+0.00020.07%
Post-market: 0.30660.0144+4.93%16:04 EDT
Volume:123.94K
Turnover:37.24K
Market Cap:4.55M
PE:-0.37
High:0.3200
Open:0.2960
Low:0.2840
Close:0.2920
Loading ...

Company Profile

Company Name:
bioAffinity Technologies, Inc.
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
75
Office Location:
22211 West Interstate 10,Suite 1206,San Antonio,Texas,United States
Zip Code:
78257
Fax:
- -
Introduction:
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.

Directors

Name
Position
Steven Girgenti
Executive Chairman and Director
Maria Zannes
President, CEO and Director
Gary Rubin
Director
Mohsin Meghji
Director
Peter Knight
Director
Robert Anderson
Director
Stuart Diamond
Director

Shareholders

Name
Position
Michael Edwards
Chief Financial Officer
Maria Zannes
President, CEO and Director
Steven Girgenti
Executive Chairman and Director
Timothy P. Zannes
Executive Vice President, Secretary and General Counsel
Vivienne Rebel
Executive Vice President and Chief Science and Medical Officer